This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Mosaic's (MOS) Earnings and Revenues Top Estimates in Q4
by Anindya Barman
Higher realized sales prices drive Mosaic's (MOS) results in Q4. The company expects its strong performance to continue in 2019.
Reasons to Hold International Paper (IP) in Your Portfolio
by Zacks Equity Research
Solid commercial and operational performance across International Paper's (IP) three businesses is likely to drive its results.
Here's Why Momentum Investors Will Love Franco-Nevada (FNV)
by Zacks Equity Research
Does Franco-Nevada (FNV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Can FMC (FMC) Keep the Earnings Surprise Streak Alive?
by Anindya Barman
Strong expected performance of the Agricultural Solutions unit is expected to drive FMC Corp's (FMC) Q4 results.
Versum Materials (VSM) Q1 Earnings Meet, Sales Miss Estimates
by Anindya Barman
Versum Materials (VSM) has cut its sales and adjusted EBITDA guidance for fiscal 2019.
Will Higher Volumes Aid Cleveland-Cliffs' (CLF) Q4 Earnings?
by Zacks Equity Research
Cleveland-Cliffs' (CLF) Q4 results to benefit from strong demand for pellets.
Why Franco-Nevada (FNV) Could Beat Earnings Estimates Again
by Zacks Equity Research
Franco-Nevada (FNV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cabot's (CBT) Q1 Earnings Miss, Sales Surpass Estimates
by Zacks Equity Research
Cabot's (CBT) performance in Q1 hurt by weaker environment in China along with softer automotive demand and customer inventory destocking. The company lowers adjusted EPS view for fiscal 2019.
Can Arconic (ARNC) Maintain Earnings Beat Streak in Q4?
by Anindya Barman
Arconic (ARNC) will likely gain from strength across its major end-markets in Q4.
Will Lower Sales Volumes Dent Hi-Crush's (HCLP) Q4 Earnings?
by Zacks Equity Research
Our proven model does not conclusively show that Hi-Crush (HCLP) will beat earnings estimates in Q4.